Development of a novel risk prediction and risk stratification score for polycystic ovary syndrome. (15th November 2018)

• Record Type: Journal Article
• Authors: Deshmukh, Harshal; Papageorgiou, Maria; Kilpatrick, Eric S.; Atkin, Stephen L.; Sathyapalan, Thozhukat
• Is Part Of: Clinical endocrinology. Volume 90:Number 1(2019)
• Page Start: 162
• Page End: 169
• Publication Date: 2018-11-15
• Subjects: 17‐OHP -- AMH -- FAI -- PCOS -- risk score; Endocrinology -- Periodicals; 616.4005
• DOI: 10.1111/cen.13879
• Languages: English
• ISSNs: 0300-0664

Abstract

Summary: Objective: The aim of this study was to develop a simple phenotypic algorithm that can capture the underlying clinical and hormonal abnormalities to help in the diagnosis and risk stratification of polycystic ovary syndrome (PCOS). Methods: The study consisted of 111 women with PCOS fulfilling the Rotterdam diagnostic criteria and 67 women without PCOS. A Firth's penalized logistic regression model was used for independent variable section. Model optimism, discrimination and calibration were assessed using bootstrapping, area under the curve (AUC) and Hosmer‐Lemeshow statistics, respectively. The prognostic index (PI) and risk score for developing PCOS were calculated using independent variables from the regression model. Results: Firth penalized logistic regression model with backward selection identified four independent predictors of PCOS namely free androgen index [β 0.30 (0.12), P = 0.008], 17‐OHP [β = 0.20 (0.01), P = 0.026], anti‐mullerian hormone [AMH; β = 0.04 (0.01) P < 0.0001] and waist circumference [β = 0.08 (0.02), P < 0.0001]. The model estimates indicated high internal validity (minimal optimism on 1000‐fold bootstrapping), good discrimination ability (bias corrected c ‐statistic = 0.90) and good calibration (Hosmer‐Lemeshow χ 2 = 3.7865). PCOS women with a high‐risk score (q1 + q2 + q3 vs q4) presented with a worse metabolic profile characterized by a higher 2‐hour glucose ( P = 0.01), insulin ( P = 0.0003), triglycerides ( P = 0.0005), C‐reactive protein ( P < 0.0001) and low HDL‐cholesterol ( P = 0.02) as compared to those with lower risk score for PCOS. Conclusions: We propose a simple four‐variable model, which captures the underlying clinical and hormonal abnormalities in PCOS and can be used for diagnosis and metabolic risk stratification in women with PCOS.